entertainment -WSS

entertainment

author：knowledge 2025-09-27 23:02:49 - browse：85329

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Drug companies' payments and gifts affect physicians' prescribing

hotspot

WSS

Hundreds died while taking an arthritis drug, but nobody alerted patients

Multiple sclerosis has subtypes with different best treatments: study

Scientists uncover potential path to treating deadly childhood tumor

Bird flu in dairy cattle: New measures to control spread to humans

Bird flu reported in person exposed to presumably infected cattle

Venture capitalist Bob Kocher on the state of digital health

leisure time

entertainment

knowledge

Psychedelics group wrestles with new pharma identity

Pancreatic cancer is often deadly, but new discoveries are raising hope

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Researchers test human milk's ability to repair gut microbiome

Guidelines to prevent youth baseball injuries need more muscle

Scientists uncover potential path to treating deadly childhood tumor

Affirmative action in medical school literally saved lives

Multiple sclerosis has subtypes with different best treatments: study

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

focus

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Scientific mystery highlights the blind spots in genomics databases

Helping hospitals and community health centers plan for resilience

hotspot

Wikipedia

hotspot

hotspot